Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibuprofen injection for acute fever
CTR20160955Phase 3Active
- Sponsor
- Nanjing Huawei Pharmaceutical Technology Development
- Start
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ibuprofen in fever, pain, sponsored by Nanjing Huawei Pharmaceutical Technology Development. Started Jan 2017; status: active.
02
Drugs
ibuprofen
03
Conditions
feverpain
Beyond the preview
Go deeper on CTR20160955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160955.